# PHARMACOKINETIC & FLUID BIOPHYSICS MATHEMATICAL REFERENCE
**Document Code:** MATH-REF-PK-P95  
**Audience:** FDA Reviewers, Academic Investigational Review Boards (IRBs)

This reference outlines the exact mathematical models and LaTeX biophysical equations utilized by the **PefkouFL-6000mg** framework to track human cellular protection and tissue debris clearance.

## 1. EQUATION OF EQUILIBRIUM HYDROSTATIC MICRO-FLUID FLUSHING
The fluid movement across dilated capillary endothelium boundaries that drives cellular and parasitic debris removal follows the **Starling Fluid Hydrostatic Flux** equation:

$$J_v = L_p \cdot A \cdot \left[ (P_c - P_{if}) - \sigma(\pi_p - \pi_{if}) \right]$$

Where:
*   $J_v$ = Net fluid filtration velocity volume across the microvascular membrane ($\text{mL/min}$).
*   $L_p$ = Hydraulic permeability of the endothelial barrier matrix.
*   $A$ = Surface area of the capillary bed (expanded via eNOS-driven cGMP smooth muscle relaxation).
*   $P_c$ = Capillary hydrostatic pressure (the primary driver of the micro-fluid tissue sweep).
*   $P_{if}$ = Interstitial fluid hydrostatic pressure.
*   $\sigma$ = Staverman reflection coefficient (membrane protein permeability indicator).
*   $\pi_p$ = Oncotic pressure of the plasma proteins.
*   $\pi_{if}$ = Oncotic pressure of the interstitial fluids.

## 2. THE KINETICS OF REDOX HAT ERYTHROCYTE SHIELDING
The physical preservation of red blood cell membrane deformability by PefkouFL's proanthocyanidins is governed by the velocity constant of **Hydrogen Atom Transfer (HAT)** pathways:

$$R^\bullet + \text{Ar-OH} \xrightarrow{k_{\text{HAT}}} R\text{-H} + \text{Ar-O}^\bullet$$

The stabilization velocity ($k_{\text{HAT}}$) is controlled by the structural **Bond Dissociation Enthalpy (BDE)** of the plant molecule's specific hydroxyl ($\text{O-H}$) groups. Lower parent BDE parameters yield exponential velocity jumps in radical scavenging, neutralizing abstracting species ($\text{OH}^\bullet$) before they can initiate a lipid radical cascade ($L^\bullet$):

$$\text{BDE} = H^\circ(\text{Ar-O}^\bullet) + H^\circ(\text{H}^\bullet) - H^\circ(\text{Ar-OH})$$

## 3. BIPHASIC HUMAN STEADY-STATE ELIMINATION MODEL
Because procyanidins require colonic microbial cleavage to generate the long-acting $\gamma$-valerolactone metabolite peak ($t_{1/2} \approx 13.5\text{ hours}$), systemic accumulation across a continuous dosing interval ($\tau = 24.0\text{ hours}$) is simulated using a non-linear, two-compartment open oral pharmacokinetic model:

$$C_{ss}(t) = \left[ \frac{F \cdot D \cdot k_a}{V_d \cdot (k_a - k_e)} \right] \cdot \left[ \frac{e^{-k_e \cdot t}}{1 - e^{-k_e \cdot \tau}} - \frac{e^{-k_a \cdot t}}{1 - e^{-k_a \cdot \tau}} \right]$$
